top of page

COH

Cochlear Ltd

Healthcare Equipment and Supplies

·

Healthcare

32

comments

18

fund managers

past 90 days

About Cochlear Ltd

Cochlear Ltd. is a global leader in implantable hearing solutions. Founded in 1981 by Michael S. Hirshorn and headquartered in Sydney, Australia, the company provides medical devices to address hearing loss. Cochlear operates through four primary segments: Americas, EMEA, Asia Pacific, and Corporate and Other. The firm focuses on the design, manufacture, and distribution of advanced hearing technologies to improve patient outcomes worldwide.

Commentary Volume

32

Comments

18

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$6B

Fund managers

18 managers

First covered

31 Mar 2024

Last updated

15 May 2026

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Cochlear Ltd (ASX:COH)

Frequently asked questions

Who is investing in Cochlear Ltd (ASX:COH)?

Fund managers including ELM Responsible Investments, Ten Cap, Antares Capital, Selector Funds Management, Firetrail Investments, Elston Asset Management, Pendal Group, Blackwattle Investment Partners, Solaris Investment Management, Yarra Capital Management, Hyperion Asset Management, Ellerston Capital, Perennial Partners, First Sentier Investors, Regal Funds Management, Vinva Investment Management, ECP Asset Management and SG Hiscock & Company have invested in Cochlear Ltd (ASX:COH).

What is the short interest in Cochlear Ltd (ASX:COH)?

The short interest in Cochlear Ltd (ASX:COH) is 3.60% which makes it the 62nd most shorted stock on the ASX. Of the 65.4M shares that Cochlear Ltd has on issue, 2.4M have been sold short.

What does Cochlear Ltd (ASX:COH) do?

Cochlear Ltd. is a global leader in implantable hearing solutions. Founded in 1981 by Michael S. Hirshorn and headquartered in Sydney, Australia, the company provides medical devices to address hearing loss. Cochlear operates through four primary segments: Americas, EMEA, Asia Pacific, and Corporate and Other. The firm focuses on the design, manufacture, and distribution of advanced hearing technologies to improve patient outcomes worldwide.

bottom of page